Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05375344
Other study ID # 849788
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 9, 2022
Est. completion date May 2026

Study information

Verified date August 2023
Source University of Pennsylvania
Contact Uduak U Andy, MD
Phone (215) 662-7709
Email uduakumoh.andy@pennmedicine.upenn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A prospective, two-arm randomized clinical trial utilizing a multidimensional intervention to reduce falls in older women with Urinary Urge Incontinence. The intervention consist of general balance and strength training, bladder training and urge suppression, and home hazard assessments. The control group will receive informational booklets on fall prevention and behavioral treatment for urinary urge incontinence.


Recruitment information / eligibility

Status Recruiting
Enrollment 375
Est. completion date May 2026
Est. primary completion date May 2026
Accepts healthy volunteers No
Gender Female
Age group 70 Years and older
Eligibility Inclusion Criteria: - Female - 70 or older - Living independently in the community - Willingness to be randomized. - Ability to read and understand English - Be able to provide informed consent - Low physical activity (physically active for 30 minutes or more less than or equal to 2 days per week on average over the past 6 months) per PAS - Ambulatory (defined as patient not confined to bed or wheelchair OR ability to walk with or without an assistive device) - Self-reported moderate to severe urge-predominant UI based on the ICIQ-SF > 6 (Q 1+2+3) - Not planning to initiate new UI or overactive bladder (OAB) treatment during the study duration - Capable of participation in an exercise program without exacerbating any pre-existing condition(s), as determined by their personal physician Exclusion Criteria: - Unable to communicate in English - Non-ambulatory - Pelvic organ prolapse passed the hymen (per patient report) - Undergoing active treatment for cancer (other than non-melanoma skin cancer) - Uncorrected visual or hearing loss. - Other urinary conditions or procedures that may affect continence status for example: urethral diverticulum, previous augmentation cystoplasty - Progressive neurodegenerative disease e.g. Parkinson's disease, multiple sclerosis per patient report - History of stroke or carotid sensitivity (i.e. syncopal falls) per patient report - Unstable cardiac disease per patient report - Fracture or joint replacement within the last six months per patient report - Significant cognitive impairment (defined as a modified TICs score of < 27) - Not willing to sign Consent Form - ICIQ-SF < 6 (Q 1+2+3) - Primary care provider says no to enrollment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise Group
Home-based exercise group intervention

Locations

Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in number of falls between the baseline visit and 1 year number of falls reported in a falls diary 12 months
Secondary Change in urinary incontinence score on the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) between baseline visit and 1 year Change in International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF). A minimum score is 0, a maximum score is 21 with a higher score indicating higher severity. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06201013 - Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children N/A
Completed NCT02001714 - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms N/A
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Enrolling by invitation NCT05404386 - Effect of Mobile Application on Urinary Incontinence N/A
Recruiting NCT05362292 - TReating Incontinence for Underlying Mental and Physical Health Phase 4
Completed NCT01959347 - Combined Treatment for Mixed Incontinence Phase 3
Recruiting NCT04271852 - An Experimental Protocol for the Study of Brain Functional Magnetic Resonance Imaging in Female With Urgent Urinary Incontinence N/A
Completed NCT01971437 - Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder N/A
Terminated NCT01464372 - Electromagnetic Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder Phase 3
Completed NCT04528784 - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis N/A
Recruiting NCT05874375 - UCon Treatment of Overactive Bladder (OAB) in Males N/A
Recruiting NCT05735522 - Effectiveness of Magnetic Stimulation in the Treatment of Female UUI. N/A
Active, not recruiting NCT03327948 - Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt N/A
Completed NCT04652869 - Mindfulness + tDCS to Reduce Urgency Incontinence in Women N/A
Completed NCT03543566 - Bladder Antimuscarinic Medication and Accidental Bowel Leakage
Completed NCT01110278 - Examining Bladder Control Using Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI) N/A
Active, not recruiting NCT05308979 - Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial Phase 4
Recruiting NCT05250908 - INTIBIA Pivotal Study N/A
Withdrawn NCT02434874 - Sacral Nerve Stimulation to Treat Urgency Urinary Incontinence With Wireless Neuromodulation N/A
Completed NCT04024085 - Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis